(Q46129667)
Statements
1 reference
Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases (English)
1 reference
1 reference
M Klinger
1 reference
S Eipeldauer
1 reference
B Herberger
1 reference
D Tamandl
1 reference
M Dorfmeister
1 reference
C Koelblinger
1 reference
B Gruenberger
1 reference
T Gruenberger
1 reference
5 February 2009
1 reference
35
1 reference
5
1 reference
515-520
1 reference